COVID-19 and Private Equity: Three Reasons Why Deal-Making Will Prove More Resilient than Feared Peter Ward Read More
Life Sciences & Pharma Executive Insights Maximizing Oncology Success Through World-Class Guideline and Compendia Strategies February 18, 2020 National Comprehensive Cancer Network (NCCN) recommendations are considered to be the gold standard for public and private insurers to use in making…
Life Sciences & Pharma Special Report Heading East: Biopharma International Expansion to China and Asia June 4, 2018 China’s rapidly growing economy has helped drive unprecedented growth in its healthcare market. Driven by pro-innovation and pro-biotechnology policy…
